JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Dairy Science Vol. 75 No. 12 3416-3431
© 1992 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pell, A. N.
Right arrow Articles by Hintz, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pell, A. N.
Right arrow Articles by Hintz, R. L.

Effects of a Prolonged-Release Formulation of Sometribove (n-Methionyl Bovine Somatotropin) on Jersey Cows

A. N. Pell 1, D. S. Tsang 1, B. A. Howlett 1, M. T. Huyler 1, V. K. Meserole 2, W. A. Samuels 2, G. F. Hartnell 2, and R. L. Hintz 2

1 Department of Animal Science, University of Vermont, Burlington 05405
2 Monsanto Company, Animal Sciences Division, St. Louis, MO 63198

Milk production, feed efficiency, health, and reproduction were evaluated in 46 Jersey cows that received either 500 mg of sometribove (n-methionyl bST) in a prolonged-release formulation or an equivalent volume of excipient bi-weekly beginning at 60 ± 3 DIM. Cows were fed a TMR for ad libitum intake and were milked twice daily. Treatment with sometribove increased 3.5% FCM production 5.3 kg/d (31.4%) over controls. Milk composition was not changed, except that milk P content averaged 51 ppm higher in bST-treated cows. Net energy intake was 4.8 Mcal/d (22.9%) higher in the bST-treated cows than in the controls. General health of all cows was good throughout the study, but the cows treated with bST had more cases of mastitis than did the control cows. The bST treatment produced localized reactions at the site of injection in some cows, but these reactions did not affect milk production. Sometribove treatment had no effect on reproductive performance; 85% of the treated and 100% of the control cows calved successfully. Treatment with bST for a full lactation did not affect performance during the initial 60 d of the subsequent lactation.

Key Words: somatotropin • sometribove • Jersey • dairy cattle

Submitted on May 21, 1992
Accepted on July 27, 1992




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. L. Capper, E. Castaneda-Gutierrez, R. A. Cady, and D. E. Bauman
The environmental impact of recombinant bovine somatotropin (rbST) use in dairy production
PNAS, July 15, 2008; 105(28): 9668 - 9673.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
R. Draghia-Akli and M. L. Fiorotto
A new plasmid-mediated approach to supplement somatotropin production in pigs
J Anim Sci, January 1, 2004; 82(13_suppl): E264 - 269.
[Abstract] [Full Text] [PDF]

Home page
 J DAIRY SCIHome page
R. A. Pershing, M. C. Lucy, W. W. Thatcher, and L. Badinga
Effects of BST on Oviductal and Uterine Genes Encoding Components of the IGF System in Lactating Dairy Cows
J Dairy Sci, December 1, 2002; 85(12): 3260 - 3267.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Dairy Science Association ®.